Legal & General Group
GBIO

Legal & General Group’s Generation Bio GBIO Stock Holding History

Legal & General Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-392
Closed -$1.59K – 3459
2025
Q1 		$1.59K Hold
392
– – ﹤0.01% 3364
2024
Q4 		$4.15K Hold
392
– – ﹤0.01% 3353
2024
Q3 		$9.68K Hold
392
– – ﹤0.01% 3280
2024
Q2 		$11.1K Hold
392
– – ﹤0.01% 3277
2024
Q1 		$16K Hold
392
– – ﹤0.01% 3058
2023
Q4 		$6.45K Hold
392
– – ﹤0.01% 3299
2023
Q3 		$14.9K Sell
392
-86
-18% -$4.07K ﹤0.01% 3150
2023
Q2 		$26.2K Hold
478
– – ﹤0.01% 2997
2023
Q1 		$20.5K Sell
478
-1,567
-77% -$75.8K ﹤0.01% 3061
2022
Q4 		$80.4K Buy
2,045
+148
+8% +$7.77K ﹤0.01% 2864
2022
Q3 		$100K Buy
1,897
+181
+11% +$11.3K ﹤0.01% 2825
2022
Q2 		$113K Buy
1,716
+47
+3% +$3.07K ﹤0.01% 2823
2022
Q1 		$123K Buy
1,669
+17
+1% +$985 ﹤0.01% 2817
2021
Q4 		$117K Hold
1,652
– – ﹤0.01% 2876
2021
Q3 		$414K Buy
1,652
+709
+75% +$170K ﹤0.01% 2475
2021
Q2 		$254K Buy
943
+37
+4% +$11.1K ﹤0.01% 2477
2021
Q1 		$257K Buy
906
+724
+398% +$232K ﹤0.01% 2411
2020
Q4 		$52K Buy
182
+45
+33% +$14.4K ﹤0.01% 2790
2020
Q3 		$42K Sell
137
-1,597
-92% -$382K ﹤0.01% 2750
2020
Q2 		$362K Buy
+1,734
New +$386K ﹤0.01% 2236

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Legal & General Group's GBIO Position: Q2 2025 in Review

Legal & General Group sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 392 shares — an estimated $1.59K sold.

Legal & General Group first reported a position in GBIO in Q2 2020 and held it in 20 quarters. The position peaked at $414K in Q3 2021. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Legal & General Group reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 392 Generation Bio shares in Q2 2025, an estimated $1.59K.
  • Legal & General Group first reported a position in Generation Bio in Q2 2020 and held it in 20 quarters.
  • Legal & General Group's Generation Bio position peaked at $414K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.